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Abstract 
Purpose  
The emphasis on early diagnosis to improve cancer survival has been a key factor in the development 
of cancer pathways across Europe. The aim of this analysis was to explore how the emphasis on early 
diagnosis and timely treatment is reflected in patient’s accounts of care, from the first suspicion of 
colorectal or lung cancer to their treatment in Denmark, England and Sweden. 
Method 
We recruited 155 patients in Denmark, England and Sweden who were within six months of being 
diagnosed with lung or colorectal cancer. Data were collected via semi-structured narrative 
interviews and analysed using a thematic approach.  
Results 
Participants’ accounts of quality of care were closely related to how quickly (or not) diagnosis, 
treatment and/or healthcare processes went. Kinetic metaphors as a description of care (such as 
treadmill) could be interpreted positively as participants were willing to forgo some degree of control 
and accept disruption to their lives to ensure more timely care. Drawing on wider cultural 
expectations of the benefits of diagnosing and treating cancer quickly, some participants were 
concerned that the waiting times between interventions might allow time for the cancer to grow.  
Conclusions 
Initiatives emphasising the timeliness of diagnosis and treatment are reflected in the ways some 
patients experience their care. However, these accounts were open to further contextualisation 
about what speed of healthcare processes meant for evaluating the quality of their care. Healthcare 
professionals could therefore be an important patient resource in providing reassurance and support 
about the timeliness of diagnosis or treatment. 
Keywords 
Lung cancer; colorectal cancer; time; multi-country comparison; narrative analysis; Quality of health 
care; Patients’ experiences 
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Background   
Diagnosing cancer earlier and more quickly has been a longstanding aim of healthcare providers 
across Europe and is a goal that has received renewed attention in the last decade (Butler et al., 
2013). Early diagnosis initiatives have been organised and implemented differently in each country 
(Brown et al., 2014; Richards, 2009) and have included – but were not limited to – structural 
reorganisation of services (e.g. Vedsted and Olesen, 2015); public awareness campaigns concerning 
the importance of early diagnosis (e.g. the Danish Cancer Society sponsored ‘go see your doctor if…’ 
campaign; Public Health England’s Be Clear On Cancer campaign from 2012; and the Swedish Cancer 
Foundations’ regional early diagnosis campaigns); and, use of time sensitive targets (e.g. Moffat et 
al., 2015). Such early diagnosis initiatives were enacted amongst wider healthcare and cultural 
changes whereby units of measurement become imbued with moral evaluations, so that more or 
faster are assumed – when contrary information is unavailable – to be ‘better’ (Moynihan et al., 
2012; Rosa, 2003). While the rationale for early diagnosis interventions was clear, the impact upon 
patient survival and – for this article - care now needs to be considered (Bankhead, 2017; Bastian, 
2017; Nicholson, 2017). Therefore we ask how an emphasis on temporal aspects of early diagnosis 
are reflected in patient accounts of cancer diagnosis and care. 
Past research has shown that good healthcare experiences are related to patients’ ability to narrate 
and contextualise their understandings (Bury, 1982; Frank, 2002; Levealahti et al., 2007; Lindqvist et 
al., 2008; Rasmussen and Elverdam, 2007). However, navigating through healthcare systems, with 
clinics at different sites (Brown et al., 2014), opaque medical language and specialised knowledge 
(Andersen, 2017; Salmon and Young, 2017), can present difficulties and opportunities for confusion. 
Public discussions about timeliness and cost-efficiencies can be found to have problematic 
implications for patients’ understandings of what (and when) is the right time to seek help 
(Llanwarne et al., 2017). Decisions about how, when and who to consult are therefore not only 
matters of clinical or diagnostic timeliness (efficiency), but also contain moral dimensions about what 
it is, or is not, appropriate for a “good patient” to do and what constitutes ‘good care’ (Llanwarne et 
al., 2017, Ziebland et al., 2017). Such research provides challenges to contemporary healthcare 
initiatives, such as patient centred care and shared decision making, which are premised upon a 
patient with the capacity and agency to evaluate and make decisions about their healthcare 
(Lehman, 2017; Richards et al., 2015). 
Understanding the temporal aspects of patient experiences is therefore an important component of 
providing good and ethical healthcare (Sandelowski, 1999). Studies that place patients’ experiences 
in a temporal frame draw our attention to the ways that patient accounts of good care are 
contextually and relationally dependent upon disease knowledge and illness experience (Bury, 1982; 
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Levealahti et al., 2007), understandings of the healthcare system (Llanwarne et al., 2017), and 
interactions with healthcare practitioners (HCPs) (Del Vecchio Good et al., 1994). In particular, such 
studies have demonstrated the disjuncture between the “clock” time often referred to by the 
healthcare system and/or professionals, and the patients’ embodied feelings of disease time (Davies, 
1994, 1996; Lövgren et al., 2010). Furthermore, the movement of time in experiences of cancer 
diagnosis and care can speed up, slow down, stretch, compress or disorder patient experiences of 
illness and care (Frank, 2002; MacArtney, 2015; Riessman, 2015). Therefore the focus of this paper is 
on how evaluative judgements about cancer diagnosis and care are entangled with the relationships 
between different temporal experiences (e.g. ‘clock’, ‘embodied’, ‘disease’, and ‘healthcare system’ 
time) and accounts of the movement of time (e.g. quick, slow) (Caldas and Berterö, 2012).  
Aim 
The aim of the study was to explore how the emphasis on early diagnosis and timely treatment is 
reflected in patient’s accounts of care, from the first suspicion of colorectal or lung cancer to their 
treatment in Denmark, England and Sweden. 
 
Method 
Context and design 
This study is a part of an international comparative qualitative study of patients diagnosed with lung 
or colorectal cancer and their experiences of diagnosis in Denmark, England and Sweden (see 
MacArtney et al., 2017). The study sought to use patients’ accounts to obtain and extend 
understanding of potentially modifiable factors known to influence long-term cancer survival, 
including late presentation, delayed diagnosis and referral into specialist care. The countries were 
chosen based on the results from the ICBP project showing a significant variation in survival rates for 
lung and colorectal in favour of Sweden compared to both Denmark and England (Coleman et al., 
2011).  
The analysis presented in this paper focuses on how the emphasis on early diagnosis and timely 
treatment is reflected in patient’s accounts of care. At the time of the interviews (2015) all three 
countries had, or were in the process of, implementing strategies intending to shorten the time from 
diagnosis to treatment for these types of cancer. Denmark implemented standardised care pathways 
with stipulated timeframes for cancer diagnosis from 2009 (Probst et al., 2012). England 
implemented a fast-track referral process (including ‘the two-week wait’) in 2000 (Department of 
Health, 2000). Sweden was in the planning phase to implement standardised care pathways similar 
5 
 
to the Danish routine for both cancers, and fast track systems were already available in many parts of 
the country (Brown et al., 2014; Wilkens et al., 2016).  
 
Recruitment and participants 
Adult patients (>18 years) within six months of being diagnosed with lung or colorectal cancer were 
eligible to be included in the study. These cancers affect both genders and are two of the most 
common causes of death from cancer across Europe (Ferlay et al., 2010). Recruitment took place 
across the whole of each country and a purposeful sample was used that sought to reach a maximum 
variation across gender, age, urban and rural locations, type of diagnosis, and route to diagnosis. 
Recruitment was primarily through hospital clinics supplemented with social media campaigns in 
England and Denmark. A total of 155 interviews were conducted. Demographic data and sample 
variation is provided in Table 1.  
 
Table 1: Demographic characteristics across the three countries 
 Denmark (DEN) England (ENG) Sweden (SWE) 
CC* LC** CC LC CC LC 
Number of 
participants 
28 22 25 20 30 30 
Percentage female 46% 36% 48% 50% 47% 50% 
Age range 31-50 2 0 4 2 2 2 
 51-70 19 15 13 12 14 21 
 71-90 7 7 8 6 14 7 
*Colorectal cancer; **Lung cancer 
 
Ethics 
Before participation all participants received an information letter and signed an informed consent 
form according to the (separate) ethical regulations in each country. In Denmark the Biomedical 
Research Ethics Committee System Act did not apply to the main project, as the project does not 
involve the use of human biological materials. Standard ethical protocol according to the American 
Anthropological Association was followed. In England approval was given by the Research Ethics 
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Service reference 14/NS/1035 and in Sweden by the Regional Ethics Board, Lund, Sweden, reference 
2014/819. 
 
Data collection 
All participants who decided to participate had the opportunity to choose where they preferred the 
interview to take place, with most interviews being conducted in the participant’s home. Interviews 
were conducted one-to-one, although a small number of participants wanted a family member to be 
present for support. In these cases we agreed to the patients’ request but clarified the aim of the 
study was to focus on the patients’ experiences. Interviews took place in the main language used 
within each country and lasted between 45 and 135 minutes. Five researchers with backgrounds in 
nursing (SWE x3), sociology (ENG x1), and anthropology (DEN x1) conducted the interviews. During 
the planning of the project a semi-structured interview guide was developed aiming to ensure the 
comparability between the countries and that potential cross-cultural issues were addressed 
(Chapple and Ziebland., 2017). Patient and public involvement (PPI) representatives in each country 
were invited to suggest revisions to the interview guide. All interviews began with an open question: 
‘Could you start by telling me, in your own words and in as much detail as you want, about 
everything that has happened since you first started to suspect there might be a problem with your 
health?’ and was followed by probing questions to ensure that the pre-defined areas in the interview 
guide were addressed. Before closing the recruitment process the researchers reviewed the 
demographic information collected to ensure there was suitable variation of participants. The 
teleconferences held throughout the recruitment process allowed for discussion of the themes found 
and therefore the researchers were able to agree when data saturation had been reached. All 
interviews were audio recorded and transcribed verbatim in the language in which they were 
conducted.  
 
Data analysis 
A thematic approach (Pope et al., 2000) was used to analyse the data within the country where it 
was collected (MacArtney et al., 2017). Using specialist computer software (NVivo 10), anticipated 
themes were drawn from the topic guide, and emerging themes were identified during the coding 
process. During data collection and analysis monthly teleconferences were held to discuss issues and 
identify emergent themes across the three countries. Three face-to-face workshops were also held 
between 2015 and 2016 where relevant data from each country were translated and compared, 
which were further supplemented by individual researchers visiting colleagues in 2016 and 2017.  
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At the final workshop, an emergent theme related to how timely treatment was reflected in patient’s 
accounts of care was identified and we agreed to (re)code the data to examine the accounts more 
closely. Once the excerpts were collated, they were read and discussed by four of the authors (MM, 
BHR, JM and RSA) one of whom (BHR) speaks and reads all three languages fluently. Initial findings 
were presented to co-authors, who provided further reflections and analysis. During this process 
similarities and differences within and between countries were discussed, resulting in one main 
theme; “It is important that the process goes quickly, isn’t it?” and four sub-themes. Inspired by 
Sandelowski and Leeman (2012), the theme were translated into thematic sentences, using 
participant expressions, in an effort to ease understanding of the findings by portraying complete 
ideas. The interview excerpts were translated and cleaned up with pauses, falterings, and repetitions 
removed (Riessman, 2008). 
 
Results 
“It is important that the process goes quickly, isn’t it?” 
The importance of timeliness of diagnosis and quality of care in the process of cancer diagnosis was 
shown throughout the patients’ accounts. The main theme “It is important that the process goes 
quickly, isn’t it?” related patients experiences of care to how quickly (or not) diagnosis, treatment 
and/or healthcare processes went. Within this main theme is an ambivalence in knowing what 
‘quickly’ means in relation to how the disease may progress or how the speed of care may affect 
prognosis. When exploring this ambivalence more closely we identified four sub-themes that allowed 
us to describe some of the normative and evaluative aspects of temporal narratives in cancer care: 
“It’s better to be fast, than slow”, “It went like clockwork”, "There’s nothing you can’t in an 
emergency… cancel or stop”, and “What has worried me is that everything took such a long time”.  
 
“It’s better to be fast, than slow” 
An emergent theme from all three countries was how the speed of diagnosis and treatment had 
become a master frame through which quality of care was evaluated.  
For example, 
Partner: But it was a rollercoaster from, I think you got cancer to the op, it was, bum, 
bum, bum, bum, bum and that, wasn’t it, with you.  
Participant: Yeah, it’s better to be fast, than slow. 
Partner: It was because they knew… (ENG) 
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In this excerpt we can see not only how participants’ evaluation of care were shaped by temporal 
narratives (including healthcare process and disease time), but that there was also a strong 
normative component related to how quickly something happened (“better to be fast”), which was 
related to a belief about the seriousness of the disease (“because they knew”). In some instances, 
the message that cancer should be treated quickly was reinforced by HCPs, as this participant 
recalled being told by a particularly straight talking doctor. 
As the hospital doctor told me on Tuesday: "You should be glad that you sent in the 
screening test and you came [to your appointment], because you came at the last 
minute. You should not have waited much longer, it would have been a significantly 
worse situation for you with regard to the spread of cancer throughout the body”. 
(DEN) 
Although some participants (and their clinicians) suggested there was a clear relationship between 
speed of diagnosis and treatment and good care, others were less sure how to evaluate the temporal 
significance of what was happening. In particular, we found that some participants’ accounts were 
unsure about how cancer as a disease progresses, as well as ambiguous expectations of how 
healthcare processes should work. For example, 
It felt like that was forever [the time between CT scan and surgery]. Because then they 
knew that it was a tumour, and I thought, “how much will it be growing while I'll go 
here and wait?” (SWE) 
There’s been a two weeks gap from seeing the oncologist to actually starting the 
proper treatment. And, the fact that’s it’s already in my lymph nodes . . . isn’t a good 
sign and part of you thinks, “Oh god! Shouldn’t they be doing this now?” Two weeks is 
a long time. But when you look at other people, some people are waiting over a 
month. But no I think they’ve been really quick. Really quick. (ENG) 
Or, as another participant succinctly put it, “it is important that the process goes quick, isn’t it?” 
(ENG). What is notable is how varying degrees of uncertainty (in relation to disease time) are 
entangled with questions about the speed of healthcare processes, which are implicitly related to 
concerns about their chances of survival. Two weeks can be transformed from a “long time” when 
related to disease growth and progression, to “really quick” when framed by knowledge that others 
wait “over a month”.  
 
“It went like clockwork” 
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Participants’ judgement of timely diagnosis or care often used superlative language such as 
“marvellous” or “tremendous” when their expectations were met (or exceeded). Participants also 
used analogies or metaphors to describe their experiences of quick care, for example, “it went like 
clockwork” or “it was like a hand in a glove”. Such metaphors suggest that participants’ care took 
place with minimal or little effort (on their behalf) and this was interpreted as a sign of good care.  
Some participants used metaphors indicating they or their care was moving, often quickly, such as 
“being on a roller-coaster”, or being “caught by a whirlwind”, or “being on a treadmill”. Similarly, a 
participant in Denmark described the process of care as if he was on a train that moved by itself and 
could change direction at any time based on the results from investigations or new clinical directives. 
The contemporary healthcare emphasis of patient centred care might suggest that such loss of 
agency is understood negatively. Yet when participants were asked to reflect on what these kinetic 
metaphors meant to them, it was somewhat surprising to find that a loss of agency could also be 
interpreted as a sign things were going as they should. For example, 
I think once you’re on [the treadmill], you’re on it, and that you’re being dealt with 
really. And I suppose I maybe am one of the lucky ones, that I was dealt with quickly. I 
don’t know. Is there a case of ‘Well we think we can do something here’, so things are 
moved along quicker? (ENG) 
Being on a treadmill, as above, does not take on the often-assumed negative understanding. Rather 
it is used to suggest, “we can do something” i.e. the healthcare system is working to the benefit of 
the participant. Another participant said, 
I suppose there is that slight feeling [of a loss of control], but as far as I was concerned, 
they know what they’re doing. So I just went along with it. And unless you want to 
step off and do your own thing, there’s not much you can do. (ENG) 
 
These participants described how they accepted giving a degree of control to the HCPs and 
healthcare system, as it might get them to their desired destination – treatment and cure – more 
quickly. As one participant described, “It was like the system knew what it´s doing and that I knew my 
role in it”.  
 
"There’s nothing you can’t in an emergency… cancel or stop” 
The context of getting cancer diagnosed or treated quickly was reflected in how some participants 
accounted for the action they or HCPs had to take, understanding it to be exceptional, out of the 
ordinary, or done in an “emergency”. As one participant said, 
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They [c]ould have said, ‘Come in tomorrow.’ And I’d be in there. You know, you can 
always, there’s nothing you can’t, in an emergency, that you can’t cancel or stop. If 
they’d have said [“come in now”], I’d have gone in straight away. (ENG) 
The expectation that cancer needed swift diagnosis and treatment also meant that some participants 
would be flexible in their planning to speed up the process, sometimes traveling to different 
hospitals, or as a participant in Sweden described it, “I put myself on standby” for a cancellation or 
last minute appointment. Other participants described their efforts to get potential cancer symptoms 
seen as quickly as possible, which encouraged some participants to take action that they otherwise 
might not. For example, one participant in Sweden said that he felt he had to “fight” to get access to 
health care. Having experienced delays, he described how he navigated his way around the system 
by contacting several different HCPs, to get his appointments more quickly.  
The temporal exceptionalism that cancer sometimes engendered was also reflected in some 
participants’ descriptions of the actions that their HCPs took. For example, when a physician told a 
participant that they would make a “direct referral” this was understood to be different from a 
normal (i.e. slower) referral. Turns of phrase, such as a HCP saying they “managed” to get the 
participant an earlier appointment, were taken to mean that the nature of their situation was such 
that they should not have to wait. Some participants interpreted such quickness to mean the clinical 
team was acting with a sense of urgency that was related to the seriousness of their prognosis. 
The need for timely diagnosis and treatment for cancer meant that some participants would accept 
(or seek) exceptions to the expectation of continuity of person in the patient-doctor relationship. As 
one participant said,  
If I had been in the situation where I had to wait for the same doctor to treat me 
throughout, how much time would I have to wait before I could get to talk to the doctor? 
Is it not better perhaps to make sure that the system works, that [investigations] 
reported, and the doctors use it, so that when a new doctor comes and needs to talk to 
me, he or she has familiarised him or herself? Rather than the same doctor coming each 
time and then maybe causing a week's delay. (DEN) 
Although some participants did describe situations where they benefitted from the continuity of a 
relationship with their HCP, the context of seeking a quick diagnosis (for cancer) suggests that some 
patients might find a continuity of care more preferable.  
 
“What has worried me is that everything took such a long time” 
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We have shown how some participants’ accounts drew on idea of cancer as a disease where things 
should move quickly. In particular, periods of time between investigations or care could be 
experienced as a “delay” in the absence of information that helped to contextualise the wait. Here 
we explore the role of HCP in this and in assuaging a participant’s worry and anxiety. For example, 
some of the participants who were left without information about how waiting times might affect 
their prognosis spoke of the fear and anxiety this provoked. A Swedish participant spoke of her worry 
that something was not right or that she had been forgotten, 
Yes what has worried me is that everything took such a long time, during the 
investigations . . . it always took several weeks in-between [investigations]. So you 
thought that they had forgotten you, but they did not. They did not forget. But it was 
just the feeling that you did not hear anything… (SWE) 
In moments such as these participants explained that it was not the amount of time that was the key, 
but that they did not necessarily know what the time might mean in relation to the cancer 
progression. In contrast, there were accounts of when providing a participant with information and 
support was found to ease many of the fears and anxieties. For example,  
And then I said "a whole week then?" [to wait for an appointment with a surgeon].  
“Yes. A whole week?" And then [the doctor] said, “It does not matter. Even if you 
could think that it has [grown], it has not," she said. And I've always appreciated that 
straight forwardness as well. (SWE) 
The participant’s anxiety about having to wait “a whole week” is interpreted and experienced 
differently once the doctor provides reassurance that a week’s wait will not mean her cancer has 
grown significantly. This meant that the participant went from relating to the waiting time as an 
emergency with a potential life-threatening outcome, to being reassured that a week would not 
affect her prognosis.  
The perceived importance of a quick process was also used to contextualise concerns about waiting 
for the decision from a multidisciplinary team (MDT) conference. Participants felt comfortable with 
waiting when they had received explanations about the role and purpose of the MDT, along with 
details of who would contact them to provide details of the outcomes. However, if there was a 
deviation between what they have expected (e.g. being contacted the same day as the MDT 
conference) and what was happening (not being contacted), the fear of being forgotten or that the 
cancer was growing arose. In such cases delays were experienced as unbearably long. 
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Discussion 
Methodological considerations 
The qualitative multi-country comparative study that this analysis draws upon is the first of its kind to 
study the route to cancer diagnosis across Denmark, England and Sweden (see MacArtney et al., 
2017). This research has provided us with a unique sample of participants’ accounts of the 
relationship between timeliness and quality of care. Cross-country research has the potential to 
enhance understanding of health and illness between counties, however there are potential barriers 
that needs to be addressed to ensure comparability. It has been pointed out that in cross country 
research the researchers needs to understand the context within the different countries where the 
research takes place (Haak et al., 2013) and that it is important that the they agree on the meaning of 
key concepts and terminology  to avoid discrepancy (Bogaert, et al., 2015). To ensure comparability 
potential hinders were identified and addressed during the process of developing the topic guide. For 
example, we found that a word that was considered common in one country did not exist in another 
or that the interpretation of a word was different between the countries. The research group 
therefore agreed about that the topic guides in each country needed to be similar in that the 
meaning of each question would be the same, even though this meant that the translation was not 
literal (Chapple and Ziebland., 2017). The study was limited to participants recall of events of being 
diagnosed with either colorectal or lung cancer. However, we suggest that our findings may be able 
to enhance understanding of patient experiences of other cancer and disease types. This is because 
the trope that early diagnosis might improve survival has been applied to other diseases and cancer 
types. Further, rather than focus on participants’ recall of specific events, we sought to identify 
narrative themes that shaped participants’ understandings of their diagnosis and treatment 
(Greenhalgh, 2016). This approach allowed us to concentrate on the normative assumptions shaping 
experiences and to identify how patients understood good care (Greenhalgh, 2016). What emerged 
during our analysis was that the key similarities and differences in the ways that narratives 
structured patient experiences within each country were also shared across the three countries. 
Further discussion and engagement with the literature suggested that the international context of 
cancer diagnosis and treatment, in which timely urgency is stressed, might be providing a master 
frame though which experiences in the three countries were being understood.  
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Result considerations 
This study provides insight into how patients’ accounts of quality of care can be shaped by the 
emphasis on timely diagnosis and treatment, which has been an important feature of cancer 
healthcare in northern Europe. In particular, the context of ensuring a timely diagnosis raises 
questions about how to understand patient kinetic metaphors concerning the quality of care such as, 
“whirlwind”, “treadmill”, or “roller-coaster”. On face value, they suggest a loss of agency (Del 
Vecchio Good et al., 1994), depersonalised care (Day et al., 2017), or that events are happening at a 
pace beyond the participant’s control. However, placed within a narrative whereby cancer is a 
disease that necessitates early diagnosis and treatment, the participants suggest an alternative 
interpretation. The speed of care is used to suggest the healthcare system is working, and this can 
provide a feeling of protection (Lilliehorn et al., 2010; Schaepe, 2011). This is not to say that agency is 
not important to the participants, but it is notable that it is something that can be withdrawn or 
limited if it will speed up healthcare processes. Indeed, in some cases, narratives of agency (of 
exerting or taking control), in the context of care being timely, provoked feelings of vulnerability as 
such actions raised questions about the system not working (cf Lilliehorn, et al., 2010).  
 
The healthcare system working quickly could also be taken as an indication that the participant’s 
illness was something that is being taken seriously, that something can be done, or that a cure was 
possible (Locock et al., 2016). It is important to note that participants could also interpret such 
efficiency as a ‘bad sign’, suggesting that the cancer is even more serious than previously thought. 
What connects these disparate experiences are not just normative expectations that cancer should 
be treated quickly, but that the interpretation of timeliness needed to be individualised to the 
participant’s immediate situation for an evaluation of care to be made (Andersen and Risor, 2014). 
That is, we found that the role of HCPs in contextualising disease and healthcare system 
temporalities was important for participants in making sense of whether, for example, waiting two 
weeks for an investigation was too long or very quick (Salmon and Young, 2016). This has 
consequences for everyday clinical practice and will need clinicians to be aware of the heterogeneity 
of disease progression for different cancers, as well individualise this information to help and support 
patients in interpreting what the timeframes mean for their care. There are therefore important 
implications for practice for HCPs (see Box 1).  
Implications for practice 
Awareness:  
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 HCPs should be aware that patients might draw on a wider cultural understanding that 
cancer should be diagnosed early and treated quickly when evaluating their 
healthcare.  
 Patients could choose to forgo some control over their care as they are seeking to 
achieve an early diagnosis or timely treatment.  
 
Communication:  
 The difference between patient and HCPs understanding of the timeliness of diagnosis 
and treatment can be a source of anxiety for patients when not discussed.  
 HCPs should ensure they have explicitly addressed individual patient concerns about 
what early diagnosis and timeliness of treatment means (and how it may have 
changed) at different points in the patients’ healthcare pathway. 
 
Box 1: Implications for practice 
Ideas of being exceptional or lucky have been argued to be part of patients wish to minimise the 
impact of a cancer diagnosis (Wilson and Luker, 2006) or are a personalisation of good fortune 
against a general expectation of poor care and treatment (Ziebland et al., 2011). What our study 
adds is that use of such language can also indicate that patients see their situation as serious and 
that what is needed are exceptional circumstances, good luck or fortune so that processes are “sped 
up”. If they see that they are successful in gaining such good fortune, this may compliment 
minimisation strategies (i.e. it is serious, but it is being treated quickly, so I be will be okay).   
The findings also highlight some of the burdens patients can face when seeking a timely diagnosis, 
raising important ethical questions about the (somewhat) unintended implications of early diagnosis 
initiatives (see also LLanwarne et al., 2017). In order to secure earlier investigations, diagnosis or 
treatment some participants were willing to go to great lengths such as: travelling to a distant 
hospital; place themselves under significant inconvenience and emotional stress (being available 
whenever the call came); or even forgo direct control or agency over decision making, which has 
significant legal or ethical implications for how HCPs share decision making (Chan et al., 2017). In the 
context of specialisation and multi-site care in which cancer care is delivered (Brown et al., 2014), the 
challenge for HCPs will be to support patients’ so they experience their care as coherent and feel safe 
in the system regardless of how it is organised (Salmon and Young, 2016). It also raises the question 
for future research of how initiatives that seek to emphasise agency (e.g. patient empowerment, 
autonomy, and choice) combine with the prioritisation of speed if patients’ understanding of agency 
are associated with feelings that the system is not working (for them) (Salmon and Young, 2016)?   
Our findings also provide an opportunity to reflect on circumstances in which continuity of care 
might supersede clinician’s concern for continuity of person. In a setting where patients see the 
importance of speed of diagnosis and treatment as taking precedence, good care will be judged to be 
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that which fulfils this criteria. This adds to a growing body of literature that suggests that while 
continuity on the person level (clinician) may have clinical and systemic benefits (Barker et al., 2017) 
– as well as being valued by the patient (Klarare et al., 2017) – there are circumstances in which 
continuity on the care system level is preferable (Andersen et al., 2011). 
 
 
Conclusion 
Wider discourses of timely diagnosis and treatment can have important affects upon many other key 
aspects of providing healthcare. We found that patients with colorectal and lung cancer treated in 
three northern European countries may prioritise speedy diagnosis and treatment over other 
considerations such as agency and continuity. Patients may engage in healthcare with an expectation 
that speed is important, but what that means for them is something that HCPs can provide 
reassurance about in terms of both disease timeframes and healthcare system processes.  
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